The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study
Recruiting
Observational Study
HCC - Hepatocellular Carcinoma
Psychological Distress
Immune Checkpoint Inhibitors (ICIs)
Cancer, Treatment-Related
Unresectable Hepatocellular Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 700 (estimated)
- Sponsor
- Guilin Medical University, China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn if emotional distress affects how well liver cancer treatment works in people receiving immunotherapy. Emotional distress means feeling anxious or depressed. The study aims to answer whether having emotional distress before treatment or changes in emotional distress during treatment affect how well immunotherapy works to treat liver cancer. Research…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Cohort 1 (SOLACE-1):
Inclusion Criteria:
* Age ≥ 18 years
* Able to complete psychological questionnaires
* Child-Pugh liver function class A
* ECOG performance status ≤ 1
* Signed informed consent
* Expected survival \> 3 months
* Diagnosed with unresectable HCC by pathology or imaging
* BCLC sta…
Contacts